Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004146 · ClinicalTrials.gov registry record · Phase 2
Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT00004146: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00004146 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004146, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. Phase II trial to study the effectiveness of carboxyamidotriazole plus radiation therapy in treating patients who have newly diagnosed supratentorial glioblastoma multiforme.
Interventions
- OTHER pharmacological study
- RADIATION radiation therapy
- DRUG carboxyamidotriazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2000-03 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004146
The ClinicalTrials.gov registry entry for NCT00004146 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which pharmacological study is the first listed.
NCT00004146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004146 about?
NCT00004146 is a clinical study titled "Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM". Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. Phase II trial to study the effectiveness of carboxya...
What is the current status of trial NCT00004146?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2000-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00004146?
The interventions under investigation include: pharmacological study (OTHER), radiation therapy (RADIATION), carboxyamidotriazole (DRUG).
Who is sponsoring clinical trial NCT00004146?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.